Arrowstreet Capital, Limited Partnership Uro Gen Pharma Ltd. Transaction History

Arrowstreet Capital, Limited Partnership

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$38.35 - $50.39 $74,092 - $97,353	-1,932 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$41.65 - $51.7 $800,429 - $993,570	-19,218 Reduced 90.87%	1,932 $91,000
Q2 2018 Aug 14, 2018	BUY	$48.35 - $65.33 $1.02 Million - $1.38 Million	21,150 New	21,150 $1.05 Million

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $251M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.